Assignee
GENCURIX INC
KR·7 granted patents·7 pending applications·3 citations·filing 2013–2024
Top patents by PatentIndex Score
14 records- 0183US10655187B2Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereofGENCURIX INC·Filed 2018·Granted May 19, 2020·3 cites·3 claims
- 0268US2024352537A1Composition for diagnosing prostate cancer by using cpg methylation changes in specific genes, and use thereofGENCURIX INC·Filed 2024·Application pending·0 cites
- 0356US2023084248A1Composition using cpg methylation changes in specific genes to diagnose bladder cancer, and use thereofGENCURIX INC·Filed 2021·Application pending·0 cites
- 0455US10428386B2Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the sameGENCURIX INC·Filed 2016·Granted Oct 1, 2019·0 cites·3 claims
- 0555US2023132750A1Composition for diagnosing colorectal cancer, rectal cancer, or colorectal adenoma using cpg methylation change of glrb gene, and use thereofGENCURIX INC·Filed 2021·Application pending·0 cites
- 0655US2023383356A1Composition for diagnosing colorectal cancer, rectal cancer or colorectal adenoma by using cpg methylation change of linc01798 gene, and use thereofGENCURIX INC·Filed 2021·Application pending·0 cites
- 0750US2024110244A1Composition for diagnosing liver cancer by using cpg methylation changes in specific genes, and use thereofGENCURIX INC·Filed 2020·Application pending·0 cites
- 0850US2013344482A1Gene for predicting the prognosis for early-stage breast cancer, and a method for predicting the prognosis for early-stage breast cancer by using the sameGENCURIX INC·Filed 2013·Application pending·0 cites
- 0947US11840733B2Method for predicting prognosis of breast cancer patientGENCURIX INC·Filed 2017·Granted Dec 12, 2023·0 cites·5 claims
- 1046US10718030B2Methods for predicting effectiveness of chemotherapy for a breast cancer patientGENCURIX INC·Filed 2018·Granted Jul 21, 2020·0 cites·6 claims
- 1145US11970732B2Method for determining nucleic acid quality of biological sampleGENCURIX INC·Filed 2018·Granted Apr 30, 2024·0 cites·9 claims
- 1245US11220716B2Methods for predicting the prognosis of breast cancer patientGENCURIX INC·Filed 2018·Granted Jan 11, 2022·0 cites·8 claims
- 1342US11261482B2Composition for detecting epidermal cell growth factor receptor gene mutation, and kit comprising sameGENCURIX INC·Filed 2017·Granted Mar 1, 2022·0 cites·13 claims
- 1434US2016102359A1Genetic marker for early breast cancer prognosis prediction and diagnosis, and use thereofGENCURIX INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →